Assess whether a top customer is actually sticky (22d2c0)

Situation

A strategic buyer looking at a carve-out from a conglomerate cannot treat a CIM that omitted a material litigation as color commentary on regulatory-approval critical-path calendar. Working-capital true-up analyst must close a top customer is actually sticky from that extract under M&A Due Diligence / Legal, IP, and Regulatory.

Decision

Working-capital true-up analyst in a strategic buyer looking at a carve-out from a conglomerate must choose Proceed / Reprice / Walk / Hold using regulatory-approval critical-path calendar after a CIM that omitted a material litigation.

Hypotheses to test

• Regulatory-approval critical-path calendar reads as Proceed once a CIM that omitted a material litigation is lined up to the same M&A Due Diligence population.
• Regulatory-approval critical-path calendar is closer to Reprice after a CIM that omitted a material litigation; Proceed would over-claim this Legal, IP, and Regulatory extract.
• Walk is still live in regulatory-approval critical-path calendar for working-capital true-up analyst in a strategic buyer looking at a carve-out from a conglomerate.
• Regulatory-approval critical-path calendar is missing the fact working-capital true-up analyst needs after a CIM that omitted a material litigation; stop this M&A Due Diligence close.

Analysis required

• Tie quality-of-earnings, working-capital, and contingent items in regulatory-approval critical-path calendar to a top customer is actually sticky.
• Name the document working-capital true-up analyst still needs before signing.
• Test whether a CIM that omitted a material litigation is a diligence gap, a price chip, or a walk-away.
• For this M&A Due Diligence Legal, IP, and Regulatory file, read regulatory-approval critical-path calendar against a CIM that omitted a material litigation and write the one fact that would move a top customer is actually sticky for working-capital true-up analyst.

Recommendation

Choose Proceed / Reprice / Walk / Hold on this M&A Due Diligence / Legal, IP, and Regulatory packet (regulatory-approval critical-path calendar after a CIM that omitted a material litigation). If regulatory-approval critical-path calendar cannot force a M&A Due Diligence label under Legal, IP, and Regulatory, stop. If regulatory-approval critical-path calendar after a CIM that omitted a material litigation cannot support Proceed versus Reprice on this M&A Due Diligence Legal, IP, and Regulatory close, working-capital true-up analyst must do not proceed, reprice, or walk on a quality-of-earnings fact the packet does not carry.